Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker IRWD
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Tammi L. Gaskins Officer | IRWD Ironwood Pharmaceuticals, Inc. | 6,666 | $32.3K | — | Nov 16, 2026 | — | Form 144 ↗ |
| Sep 23, 2026 | Michael Shetzline Former Officer | IRWD Ironwood Pharmaceuticals, Inc. | 83,306 | $377.4K | — | Sep 24, 2026 | — | Form 144 ↗ |
| Jul 7, 2026 | Ronald Silver Officer | IRWD Ironwood Pharmaceuticals, Inc. | 127,890 | $560.2K | 10b5-1 | Jul 7, 2026 | Form 4 ↗ 2 days later · 127,890 shares | Form 144 ↗ |
| Jun 16, 2026 | Julie McHugh Director | IRWD Ironwood Pharmaceuticals, Inc. | 21,571 | $79.6K | 10b5-1 | Jun 16, 2026 | Form 4 ↗ 1 day later · 21,571 shares | Form 144 ↗ |
| Feb 20, 2026 | Tammi L. Gaskins Officer | IRWD Ironwood Pharmaceuticals, Inc. | 19,775 | $91.2K | — | Feb 23, 2026 | Form 4 ↗ 5 days later · 21,526 shares | Form 144 ↗ |
| Feb 20, 2026 | Gregory S. Martini Officer | IRWD Ironwood Pharmaceuticals, Inc. | 20,163 | $93.0K | — | Feb 23, 2026 | Form 4 ↗ 5 days later · 21,944 shares | Form 144 ↗ |
| Feb 20, 2026 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 33,528 | $154.6K | — | Feb 23, 2026 | Form 4 ↗ 5 days later · 36,492 shares | Form 144 ↗ |
| Feb 20, 2026 | Michael Shetzline Officer | IRWD Ironwood Pharmaceuticals, Inc. | 29,937 | $138.0K | — | Feb 23, 2026 | Form 4 ↗ 5 days later · 32,582 shares | Form 144 ↗ |
| Feb 20, 2026 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 182,185 | $839.9K | — | Feb 23, 2026 | Form 4 ↗ 5 days later · 198,283 shares | Form 144 ↗ |
| Jan 5, 2026 | Ronald Silver Officer | IRWD Ironwood Pharmaceuticals, Inc. | 35,416 | $151.2K | 10b5-1 | Jan 5, 2026 | Form 4 ↗ 2 days later · 35,416 shares | Form 144 ↗ |
| Nov 14, 2025 | Tammi L. Gaskins Officer | IRWD Ironwood Pharmaceuticals, Inc. | 6,324 | $21.3K | — | Nov 17, 2025 | Form 4 ↗ 5 days later · 6,016 shares | Form 144 ↗ |
| Aug 8, 2025 | Tammi L. Gaskins Officer | IRWD Ironwood Pharmaceuticals, Inc. | 1,406 | $1,237 | — | Aug 11, 2025 | Form 4 ↗ 5 days later · 1,316 shares | Form 144 ↗ |
| Aug 8, 2025 | Gregory S. Martini Officer | IRWD Ironwood Pharmaceuticals, Inc. | 1,351 | $1,189 | — | Aug 11, 2025 | Form 4 ↗ 5 days later · 1,265 shares | Form 144 ↗ |
| Aug 8, 2025 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 8,281 | $7,287 | — | Aug 11, 2025 | Form 4 ↗ 5 days later · 7,754 shares | Form 144 ↗ |
| May 16, 2025 | Tammi L. Gaskins Officer | IRWD Ironwood Pharmaceuticals, Inc. | 2,814 | $1,660 | — | May 19, 2025 | Form 4 ↗ 4 days later · 2,563 shares | Form 144 ↗ |
| May 16, 2025 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 14,661 | $8,650 | — | May 19, 2025 | Form 4 ↗ 4 days later · 13,353 shares | Form 144 ↗ |
| Feb 7, 2025 | Gregory S. Martini Officer | IRWD Ironwood Pharmaceuticals, Inc. | 12,347 | $24.0K | — | Feb 10, 2025 | Form 4 ↗ 5 days later · 12,052 shares | Form 144 ↗ |
| Feb 7, 2025 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 39,889 | $77.4K | — | Feb 10, 2025 | Form 4 ↗ 5 days later · 38,938 shares | Form 144 ↗ |
| Feb 7, 2025 | Michael Shetzline Officer | IRWD Ironwood Pharmaceuticals, Inc. | 42,274 | $82.0K | — | Feb 10, 2025 | Form 4 ↗ 5 days later · 41,269 shares | Form 144 ↗ |
| Feb 7, 2025 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 142,454 | $276.4K | — | Feb 10, 2025 | Form 4 ↗ 5 days later · 139,064 shares | Form 144 ↗ |
| Dec 27, 2024 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 60,434 | $241.7K | — | Dec 27, 2024 | — | Form 144 ↗ |
| Nov 15, 2024 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 6,090 | $25.0K | — | Nov 18, 2024 | Form 4 ↗ 5 days later · 5,360 shares | Form 144 ↗ |
| Nov 15, 2024 | Emany Sravan Kumar Officer | IRWD Ironwood Pharmaceuticals, Inc. | 12,500 | $51.4K | — | Nov 18, 2024 | Form 4 ↗ 5 days later · 11,001 shares | Form 144 ↗ |
| Aug 9, 2024 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 11,726 | $47.5K | — | Aug 12, 2024 | — | Form 144 ↗ |
| Jun 10, 2024 | Julie McHugh Director | IRWD Ironwood Pharmaceuticals, Inc. | 22,766 | $144.6K | 10b5-1 | Jun 10, 2024 | — | Form 144 ↗ |
| Jun 7, 2024 | Catherine Moukheibir Director | IRWD Ironwood Pharmaceuticals, Inc. | 35,574 | $234.8K | — | Jun 7, 2024 | — | Form 144 ↗ |
| Jun 6, 2024 | Catherine Moukheibir Director | IRWD Ironwood Pharmaceuticals, Inc. | 44,426 | $282.5K | — | Jun 6, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 25,105 | $166.7K | — | May 20, 2024 | — | Form 144 ↗ |
| May 17, 2024 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 19,228 | $127.7K | — | May 20, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Michael Shetzline Officer | IRWD Ironwood Pharmaceuticals, Inc. | 17,820 | $118.3K | — | May 20, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 74,705 | $496.0K | — | May 20, 2024 | — | Form 144 ↗ |
| Feb 9, 2024 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 55,429 | $825.9K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 9, 2024 | Michael Shetzline Officer | IRWD Ironwood Pharmaceuticals, Inc. | 45,181 | $673.2K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 9, 2024 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 207,264 | $3.1M | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 9, 2024 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 11,519 | $171.6K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Dec 14, 2023 | Marla L. Kessler Director | IRWD Ironwood Pharmaceuticals, Inc. | 9,926 | $111.1K | 10b5-1 | Dec 14, 2023 | — | Form 144 ↗ |
| Nov 17, 2023 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 3,859 | $36.4K | — | Nov 20, 2023 | — | Form 144 ↗ |
| Aug 11, 2023 | John Minardo Officer | IRWD Ironwood Pharmaceuticals, Inc. | 8,281 | $80.4K | — | Aug 14, 2023 | — | Form 144 ↗ |
| Aug 1, 2023 | Jason Rickard Officer | IRWD Ironwood Pharmaceuticals, Inc. | 30,000 | $335.1K | — | Aug 1, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Jason Rickard Officer | IRWD Ironwood Pharmaceuticals, Inc. | 40,309 | $448.1K | — | Jun 7, 2023 | — | Form 144 ↗ |
| May 30, 2023 | Thomas McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 26,632 | $285.0K | 10b5-1 | May 30, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Andrew Davis Officer | IRWD Ironwood Pharmaceuticals, Inc. | 7,165 | $73.2K | — | May 22, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Michael Shetzline Officer | IRWD Ironwood Pharmaceuticals, Inc. | 11,731 | $119.9K | — | May 22, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Thomas A. McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 40,907 | $418.1K | — | May 22, 2023 | — | Form 144 ↗ |
| May 8, 2023 | Thomas McCourt Officer, Director | IRWD Ironwood Pharmaceuticals, Inc. | 21,148 | $224.7K | 10b5-1 | May 8, 2023 | — | Form 144 ↗ |
45 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances